Suggestions

Du même auteur

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Archive ouverte | Tao, Y. | CCSD

International audience. To evaluate potential synergistic effect of pembrolizumab with radiotherapy (RT) compared with a standard-of-care (SOC) cetuximab-RT in patients with locally advanced-squamous cell carcinoma ...

Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' randomized trial

Archive ouverte | Bourhis, J. | CCSD

ESMO Virtual Congress, ELECTR NETWORK, SEP 19-OCT 18, 2020. International audience

854MO Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial

Archive ouverte | Tao, Y. | CCSD

International audience. BackgroundBased on a potential synergistic effect of anti–PD-L1 avelumab plus cetuximab and RT, this combination was tested in a randomized trial against two standards of care (SOC) in LA-SCC...

Chargement des enrichissements...